Domingo, 28 Febrero, 2021

Synergy Pharmaceuticals, Inc. (SGYP) Set to Announce Quarterly Earnings on Thursday

Manuel Armenta | 23 Febrero, 2017, 10:41

The stock's quarterly performance indicates a Positive momentum of 10.97 percent, whereas its last one month trend is Pessimistic with -5.3 percent. The consensus rating is 2.4, suggesting the market has given up on the stock. These analysts and investment firms use various valuation methods to decide a price target for a stock.

For the most recent quarter end, Synergy Pharmaceuticals, Inc. reported Annual Earnings of $-0.22.

Exelixis, Inc. (NASDAQ:EXEL)went up 2.08% during trading on the U.S. exchange where it had a trading capacity of 5M shares. (NASDAQ:SGYP) to Buy by settling a price target of $15 on 5/09/16. Rodman & Renshaw Maintains the stock to Buy on 3/21/16 by stationing a price target of $16.

Several analysts have released their opinion on Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to Neutral with a price target of $7.

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) went up 0.17% during trading on the USA exchange when it had traded 4.81M shares. The stock stands almost -18.46% off versus the 52-week high and 133.2% away from the 52-week low.

Several sell side analysts reviewed their recommendations on Synergy Pharmaceuticals, Inc. Rodman & Renshaw upped their price target on shares of Synergy Pharmaceuticals from $17.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, January 20th. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

In the last Quarter, Synergy Pharmaceuticals, Inc.

Synergy Pharmaceuticals, a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. (NASDAQ:SGYP) could bring EPS of $-0.2/share. This is the current Zacks consensus EPS which was calculated at the time of writing. Thus the company showed an Earnings Surprise of -10 Percent. Post opening the session at $6.07, the shares hit an intraday low of $5.76 and an intraday high of $6.12 and the price was in this range throughout the day.

The highest price SGYP stock touched in the last 12 month was $7.15 and the lowest price it hit in the same period was $2.5. It has been assigned a low target price of $6.5 and a high target price of $18. The stock is now trading with a distance of 20-Day Simple Moving Average (SMA20) of -5.51%. The Moving Average SMA50 is -2.35% while SMA200 is 19.35%. Synergy Pharmaceuticals Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner PAULSON & CO. The net money flow of the block trade stood at a $0.44, signaling heavy buying.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals. Its weekly performance showed downward trend of -1.62 percent. The Relative Volume value measured for Synergy Pharmaceuticals, Inc. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

The stock now has its Annual Dividend of $0 and an annual Dividend Yield of 0 Percent. 19, 2016, the shares were put up for sale at an average price of $5.76, raking in a sum of $14,504.